Entity Central Index Key
Cover [Abstract]
Document and entity information.
Document and entity information table.
Document And Entity Information [Table]
Document And Entity Information [Table]
Class of Stock
Statement Class Of Stock [Axis]
Class of Stock
Class Of Stock [Domain]
American depositary share.
American Depositary Shares
American Depositary Share [Member]
Ordinary shares.
Ordinary Shares
Ordinary Shares [Member]
Document And Entity Information [Line Items]
Document And Entity Information [Line Items]
Document Type
Document Type
Amendment Flag
Amendment Flag
Document Period End Date
Document Period End Date
Document Fiscal Year Focus
Document Fiscal Year Focus
Document Fiscal Period Focus
Document Fiscal Period Focus
Trading Symbol
Trading Symbol
Entity Registrant Name
Entity Registrant Name
Entity Central Index Key
Current Fiscal Year End Date
Current Fiscal Year End Date
Entity Filer Category
Entity Filer Category
Entity Emerging Growth Company
Entity Emerging Growth Company
Entity Small Business
Entity Small Business
Entity Current Reporting Status
Entity Current Reporting Status
Entity Interactive Data Current
Entity Interactive Data Current
Entity Shell Company
Entity Shell Company
Entity File Number
Entity File Number
Entity Incorporation, State or Country Code
Entity Incorporation State Country Code
Entity Address, Address Line One
Entity Address Address Line1
Entity Address, Address Line Two
Entity Address Address Line2
Entity Address, Address Line Three
Entity Address Address Line3
Entity Address, City or Town
Entity Address City Or Town
Entity Address, Postal Zip Code
Entity Address Postal Zip Code
Entity Address, Country
Entity Address Country
City Area Code
City Area Code
Local Phone Number
Local Phone Number
Document Quarterly Report
Document Quarterly Report
Document Transition Report
Document Transition Report
Security12b Title
Security12b Title
Security Exchange Name
Security Exchange Name
Entity Common Stock, Shares Outstanding
Entity Common Stock Shares Outstanding
Accrued liabilities and other liabilities current.
Statement Of Financial Position [Abstract]
ASSETS
Assets [Abstract]
Current Assets:
Assets Current [Abstract]
Cash and cash equivalents
Cash And Cash Equivalents At Carrying Value
Restricted cash
Restricted Cash And Cash Equivalents At Carrying Value
Short-term investments
Short Term Investments
Accounts receivable, net
Accounts Receivable Net Current
Inventory
Inventory Net
Prepaid and other current assets
Prepaid Expense And Other Assets Current
Total current assets
Assets Current
Property, plant and equipment, net
Property Plant And Equipment Net
Long-term investments
Long Term Investments
Operating lease right-of-use asset
Operating Lease Right Of Use Asset
Other long-term assets
Other Assets Noncurrent
Intangible asset, net
Finite Lived Intangible Assets Net
TOTAL ASSETS
Assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Liabilities And Stockholders Equity [Abstract]
Current Liabilities:
Liabilities Current [Abstract]
Accounts payable
Accounts Payable Current
Accrued expenses and other current liabilities
Accrued Liabilities And Other Liabilities Current
Debt from royalty-bearing instrument
Long Term Debt Current
Deferred revenue, current
Contract With Customer Liability Current
Total current liabilities
Liabilities Current
Long-Term Liabilities:
Liabilities Noncurrent [Abstract]
Deferred revenue, long-term
Contract With Customer Liability Noncurrent
Long-term operating lease liability
Operating Lease Liability Noncurrent
Other long-term liabilities
Other Liabilities Noncurrent
Total liabilities
Liabilities
Commitments and contingencies (Note 6)
Commitments And Contingencies
Stockholders’ Equity:
Stockholders Equity [Abstract]
Series A Convertible Preferred Stock, £0.05 par, unlimited authorized; 289,317,460 shares issued and outstanding as of March 31, 2020 and December 31, 2019 (equivalent to 28,931,746 ordinary shares upon future consolidation and redesignation at a 10:1 ratio)
Preferred Stock Value
Common stock, £0.50 par, unlimited authorized; 367,378,806 issued, 361,707,982 outstanding as of March 31, 2020; 365,014,893 issued, 360,103,901 outstanding as of December 31, 2019
Common Stock Value
Additional paid-in capital
Additional Paid In Capital
Treasury stock; 5,670,824 shares as of March 31, 2020; 4,910,992 shares as of December 31, 2019
Treasury Stock Value
Accumulated deficit
Retained Earnings Accumulated Deficit
Total stockholders’ equity
Stockholders Equity
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
Liabilities And Stockholders Equity
Preferred stock, equivalent ordinary shares upon future conversion outstanding.
Preferred stock, par value
Preferred Stock Par Or Stated Value Per Share
Preferred stock, shares authorized, unlimited
Preferred Stock Shares Authorized Unlimited
Preferred stock, issued
Preferred Stock Shares Issued
Preferred stock, shares outstanding
Preferred Stock Shares Outstanding
Preferred stock, equivalent ordinary shares upon future consolidation outstanding
Preferred Stock Equivalent Ordinary Shares Upon Future Conversion Outstanding
Common stock, par value
Common Stock Par Or Stated Value Per Share
Common stock, shares authorized, unlimited
Common Stock Shares Authorized Unlimited
Common stock, issued
Common Stock Shares Issued
Common stock, outstanding
Common Stock Shares Outstanding
Treasury stock, shares
Treasury Stock Shares
Income Statement [Abstract]
Statement [Table]
Statement [Table]
Product and Service
Product Or Service [Axis]
Product and Service
Products And Services [Domain]
Product Revenue, Net
Product [Member]
Licensing and royalty.
Licensing and Royalty Revenue
Licensing And Royalty [Member]
Statement [Line Items]
Statement [Line Items]
Total revenue, net
Revenue From Contract With Customer Excluding Assessed Tax
Less: Cost of goods sold
Cost Of Goods And Services Sold
Gross margin
Gross Profit
Operating expenses:
Operating Expenses [Abstract]
Selling, general and administrative
Selling General And Administrative Expense
Research and development
Research And Development Expense
Total operating expenses
Operating Expenses
Operating loss
Operating Income Loss
Interest income (expense), net
Interest Income Expense Nonoperating Net
Other (expense) income, net
Other Nonoperating Income Expense
Loss from operations before taxes
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
Income tax benefit
Income Tax Expense Benefit
Net loss
Net Income Loss
Loss per share:
Earnings Per Share Basic And Diluted [Abstract]
Basic
Earnings Per Share Basic
Diluted
Earnings Per Share Diluted
Weighted average shares:
Weighted Average Number Of Shares Outstanding [Abstract]
Basic
Weighted Average Number Of Shares Outstanding Basic
Diluted
Weighted Average Number Of Diluted Shares Outstanding
Statement Of Stockholders Equity [Abstract]
Equity Components
Statement Equity Components [Axis]
Equity Component
Equity Component [Domain]
Preferred Shares
Preferred Stock [Member]
Common Shares
Common Stock [Member]
Treasury Shares
Treasury Stock [Member]
Additional Paid-in Capital
Additional Paid In Capital [Member]
Accumulated Deficit
Retained Earnings [Member]
Balance
Balance (in shares)
Shares Outstanding
Exercise of stock options
Stock Issued During Period Value Stock Options Exercised
Exercise of stock options (in shares)
Stock Issued During Period Shares Stock Options Exercised
Vesting of restricted stock units
Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
Vesting of restricted stock units (in shares)
Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
Stock-based compensation
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
Loss for the period
Balance
Balance (in shares)
Depreciation and amortization excluding amortization of intangible assets.
Initial recognition of operating lease right-of-use asset.
Cash Paid During Period For [Abstract]
Statement Of Cash Flows [Abstract]
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Cash Provided By Used In Operating Activities [Abstract]
Net loss
Profit Loss
Adjustments to reconcile loss to net cash used in operating activities:
Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]
Depreciation and amortization
Depreciation And Amortization Excluding Amortization Of Intangible Assets
Accretion of investments
Accretion Amortization Of Discounts And Premiums Investments
Stock-based compensation
Share Based Compensation
Amortization of debt discount and debt issuance costs
Amortization Of Financing Costs And Discounts
Amortization of intangible asset
Amortization Of Intangible Assets
Changes in assets and liabilities:
Increase Decrease In Operating Capital [Abstract]
Accounts receivable, net
Increase Decrease In Accounts Receivable
Inventory
Increase Decrease In Inventories
Prepaid and other current assets
Increase Decrease In Prepaid Deferred Expense And Other Assets
Other long-term assets
Increase Decrease In Other Noncurrent Assets
Interest receivable
Increase Decrease In Accrued Interest Receivable Net
Accrued interest payable
Increase Decrease In Interest Payable Net
Deferred revenue
Increase Decrease In Contract With Customer Liability
Accounts payable and other current liabilities
Increase Decrease In Accounts Payable And Other Operating Liabilities
Other long-term liabilities
Increase Decrease In Other Noncurrent Liabilities
Net cash provided by (used in) operating activities
Net Cash Provided By Used In Operating Activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Net Cash Provided By Used In Investing Activities [Abstract]
Proceeds from sales of securities
Proceeds From Sale And Maturity Of Marketable Securities
Purchase of securities
Payments To Acquire Marketable Securities
Purchases of furniture, fixtures and equipment
Payments To Acquire Property Plant And Equipment
Net cash used in investing activities
Net Cash Provided By Used In Investing Activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Net Cash Provided By Used In Financing Activities [Abstract]
Proceeds from exercise of stock options, net of transaction costs
Proceeds From Stock Options Exercised
Payment on debt from royalty-bearing instrument
Repayments Of Long Term Debt
Taxes paid related to stock-based awards
Payments Related To Tax Withholding For Share Based Compensation
Net cash used in financing activities
Net Cash Provided By Used In Financing Activities
NET DECREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD
Supplemental disclosure of cash flow information:
Supplemental Cash Flow Information [Abstract]
Cash paid during the year for:
Cash Paid During Period For [Abstract]
Interest
Interest Paid Net
Income taxes
Income Taxes Paid
Supplemental disclosure of non-cash transactions:
Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract]
Initial recognition of operating lease right-of-use asset
Initial Recognition Of Operating Lease Right Of Use Asset
Accounting Policies [Abstract]
Nature of Business and Basis of Presentation
Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block]
Significant Accounting Policies
Significant Accounting Policies [Text Block]
Goodwill And Intangible Assets Disclosure [Abstract]
Intangible Asset
Intangible Assets Disclosure [Text Block]
Inventory Disclosure [Abstract]
Inventory
Inventory Disclosure [Text Block]
Debt Disclosure [Abstract]
Debt
Debt Disclosure [Text Block]
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies
Commitments And Contingencies Disclosure [Text Block]
Equity [Abstract]
Equity
Stockholders Equity Note Disclosure [Text Block]
Co promotion agreement disclosure.
Co-promotion agreement.
Co Promotion Agreement [Abstract]
Co-Promotion Agreement
Co Promotion Agreement Disclosure [Text Block]
Revenue From Contract With Customer [Abstract]
Revenue Recognition
Revenue From Contract With Customer [Text Block]
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Development, Commercialization and Supply Agreements
Collaborative Arrangement Disclosure [Text Block]
Leases [Abstract]
Leases
Lessee Operating Leases [Text Block]
Revenue Recognition
Revenue From Contract With Customer Policy [Text Block]
Cash and Cash Equivalents and Restricted Cash
Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy
Accounts Receivable, net
Receivables Policy [Text Block]
Inventory
Inventory Policy [Text Block]
Income Taxes
Income Tax Policy [Text Block]
Loss per Share
Earnings Per Share Policy [Text Block]
Concentration of Credit Risk
Concentration Risk Credit Risk
Concentration of suppliers.
Concentration of Suppliers
Concentration Of Suppliers Policy [Text Block]
Fair Value of Financial Instruments
Fair Value Of Financial Instruments Policy
Derivative Liabilities
Derivatives Policy [Text Block]
Segment and Geographical Information
Segment Reporting Policy Policy [Text Block]
Recent Accounting Pronouncements
New Accounting Pronouncements Policy Policy [Text Block]
Summary of Impact of Accounts Receivable Reserves on Gross Trade Accounts Receivable Balances
Schedule Of Accounts Notes Loans And Financing Receivable [Text Block]
Calculation of Net Loss and Number of Shares Used to Compute Basic and Diluted Net Loss per Share
Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]
Anti-Dilutive Securities Not Included in the Computation of Net Loss or Earnings per Share
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]
Assets and Liability Measured at Fair Value on a Recurring Basis
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Table [Text Block]
Carrying Amounts and Estimated Fair Values of Debt Instruments
Schedule Of Carrying Values And Estimated Fair Values Of Debt Instruments Table [Text Block]
Schedule of Carrying Value of Intangible Asset
Schedule Of Finite Lived Intangible Assets Table [Text Block]
Schedule of Inventory
Schedule Of Inventory Current Table [Text Block]
Summary of net product revenue valuation allowances.
Summarize Activity of the Net Product Revenue Allowance and Reserve Categories
Summary Of Net Product Revenue Valuation Allowances Table [Text Block]
Changes in Balances of Contract Assets and Liabilities and Revenues Recognized
Contract With Customer Asset And Liability Table [Text Block]
Maturity Analysis of Undiscounted Payments for Operating Lease Liabilities and Reconciliation with Carrying Amount of Lease Liability
Lessee Operating Lease Liability Maturity Table [Text Block]
Number of sales professionals.
Organization, consolidation and presentation of financial statements disclosure.
Organization, consolidation and presentation of financial statements disclosure.
Organization Consolidation And Presentation Of Financial Statements Disclosure [Table]
Organization Consolidation And Presentation Of Financial Statements Disclosure [Table]
Title of Individual
Title Of Individual [Axis]
Title of Individual
Title Of Individual With Relationship To Entity [Domain]
Sales representatives and managers.
Sales Representatives and Managers
Sales Representatives And Managers [Member]
Sales representatives.
Sales Representatives
Sales Representatives [Member]
Direct sales force.
Direct Sales Force
Direct Sales Force [Member]
Direct sales force and sales representatives.
Direct Sales Force And Sales Representatives
Direct Sales Force And Sales Representatives [Member]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Line Items]
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]
Number of sales professionals
Number Of Sales Professionals
Number of operating segments
Number Of Operating Segments
Total current assets
Inventory
Other debt outstanding
Other Long Term Debt
Accounts receivable credit period
Significant accounting policies.
Significant Accounting Policies [Table]
Significant Accounting Policies [Table]
Significant Accounting Policies [Table]
Customer
Major Customers [Axis]
Customer
Name Of Major Customer [Domain]
Customer A.
Customer A
Customer A [Member]
Customer B.
Customer B
Customer B [Member]
Customer C.
Customer C
Customer C [Member]
Concentration Risk Benchmark
Concentration Risk By Benchmark [Axis]
Concentration Risk Benchmark
Concentration Risk Benchmark [Domain]
Gross Product Sales
Sales Revenue Net [Member]
Accounts Receivable
Accounts Receivable [Member]
Concentration Risk Type
Concentration Risk By Type [Axis]
Concentration Risk Type
Concentration Risk Type [Domain]
Customer Concentration Risk
Customer Concentration Risk [Member]
Debt Instrument
Debt Instrument [Axis]
Debt Instrument, Name
Debt Instrument Name [Domain]
Money market instruments.
Money Market Instruments
Money Market Instruments [Member]
Investment Type
Investment Type [Axis]
Investments
Investment Type Categorization [Member]
Short Term Investments
Short Term Investments [Member]
Long term investments.
Long Term Investments
Long Term Investments [Member]
Derivative Instrument
Derivative Instrument Risk [Axis]
Derivative Contract
Derivative Contract Type [Domain]
Embedded Derivative Financial Instruments
Embedded Derivative Financial Instruments [Member]
Segments
Statement Business Segments [Axis]
Segments
Segment [Domain]
Biopharmaceutical.
BioPharma Debt
Biopharmaceutical [Member]
Measurement Input Type
Measurement Input Type [Axis]
Measurement Input Type
Measurement Input Type [Domain]
Measurement Input, Expected Term
Measurement Input Expected Term [Member]
Statistical Measurement
Range [Axis]
Statistical Measurement
Range [Member]
Minimum
Minimum [Member]
Maximum
Maximum [Member]
Significant Accounting Policies [Line Items]
Significant Accounting Policies [Line Items]
Trade receivables, credit period
Accounts Receivable Credit Period
Schedule Of Accounts Notes Loans And Financing Receivable [Table]
Schedule Of Accounts Notes Loans And Financing Receivable [Table]
SEC Schedule, 12-09, Valuation Allowances and Reserves Type
Valuation Allowances And Reserves Type [Axis]
SEC Schedule, 12-09, Valuation Allowances and Reserves
Valuation Allowances And Reserves [Domain]
Trade Allowances
Allowance For Credit Loss [Member]
Allowance for Estimated Chargebacks [Member]
Chargebacks
Allowance For Estimated Chargebacks [Member]
Allowance for doubtful account.
Allowance for Doubtful Accounts
Allowance For Doubtful Account [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Accounts Notes And Loans Receivable [Line Items]
Gross trade accounts receivable
Accounts Receivable Gross Current
Valuation allowances and reserves
Valuation Allowances And Reserves Balance
Accounts receivable, net
Net income loss available to common stockholders basic and diluted.
Earnings Per Share [Abstract]
Net loss—basic and diluted
Net Income Loss Available To Common Stockholders Basic And Diluted
Weighted average shares outstanding—basic and diluted
Weighted Average Number Of Share Outstanding Basic And Diluted
Net loss per share—basic and diluted
Earnings Per Share Basic And Diluted
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Antidilutive Securities
Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]
Antidilutive Securities, Name
Antidilutive Securities Name [Domain]
Stock Options
Employee Stock Option [Member]
Restricted Stock Units (RSUs)
Restricted Stock Units R S U [Member]
Financial Instrument
Financial Instrument [Axis]
Financial Instruments
Transfers And Servicing Of Financial Instruments Types Of Financial Instruments [Domain]
Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Anti-dilutive securities
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
Number of customers.
Concentration risk percentage
Concentration Risk Percentage1
Number of customers
Number Of Customers
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Measurement Frequency
Fair Value By Measurement Frequency [Axis]
Measurement Frequency
Fair Value Measurement Frequency [Domain]
Fair Value, Measurements, Recurring
Fair Value Measurements Recurring [Member]
Fair Value Hierarchy and NAV
Fair Value By Fair Value Hierarchy Level [Axis]
Fair Value Hierarchy and NAV
Fair Value Measurements Fair Value Hierarchy [Domain]
Level 1
Fair Value Inputs Level1 [Member]
Level 2
Fair Value Inputs Level2 [Member]
Level 3
Fair Value Inputs Level3 [Member]
Asset Class
Fair Value By Asset Class [Axis]
Asset Class
Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain]
Money Market Fund
Money Market Funds [Member]
U.S. Treasury Shares
U S Treasury Securities [Member]
Corporate Bonds
Corporate Debt Securities [Member]
Commercial Paper
Commercial Paper [Member]
Agency security.
Agency Securities
Agency Security [Member]
Repo securities.
Repo Securities
Repo Securities [Member]
Asset Backed Securities
Asset Backed Securities [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Asset:
Assets Fair Value Disclosure [Abstract]
Asset, fair value
Assets Fair Value Disclosure
Maturities period
Debt Instrument Term
Unrealized losses on held-to-maturity securities
Held To Maturity Securities Continuous Unrealized Loss Position Fair Value
Debt Instrument [Table]
Debt Instrument [Table]
Measurement Basis
Fair Value By Measurement Basis [Axis]
Fair Value Disclosure Item Amounts [Default]
Portion At Fair Value Fair Value Disclosure [Member]
Fair Value Measurement
Fair Value Disclosure Item Amounts [Domain]
Debt from Royalty-bearing Instrument
Estimate Of Fair Value Fair Value Disclosure [Member]
Debt Instrument [Line Items]
Debt Instrument [Line Items]
Debt from royalty-bearing instrument, carrying value
Long Term Debt
Debt from royalty-bearing instrument, estimated fair value
Long Term Debt Fair Value
Derivative liability fair value assumptions expected term.
Fair value assumptions coupon rate.
Fair value assumptions, comparable yield to maturity.
Maximum repayment of future revenue and receivables
Other Commitment
Derivative liability fair value assumptions, term
Derivative Liability Fair Value Assumptions Expected Term
Derivative liability fair value assumption, coupon rate
Fair Value Assumptions Coupon Rate
Derivative liability fair value assumptions, market yields
Fair Value Assumptions Comparable Yield To Maturity
Fair value of embedded derivative liability
Embedded Derivative Fair Value Of Embedded Derivative Liability
Gain (loss) on change in fair value of derivative liabilities
Unrealized Gain Loss On Derivatives
Milestone payment received.
Schedule Of Finite Lived Intangible Assets [Table]
Schedule Of Finite Lived Intangible Assets [Table]
Regulatory Agency
Regulatory Agency [Axis]
Regulatory Agency
Regulatory Agency [Domain]
Food and drug administration.
Food and Drug Administration
Food And Drug Administration [Member]
Finite Lived Intangible Assets [Line Items]
Finite Lived Intangible Assets [Line Items]
Intangible asset estimated weighted- average remaining useful life
Finite Lived Intangible Assets Remaining Amortization Period1
Milestone payment achieved
Milestone Payment Received
Increase in intangible assets
Increase Decrease In Intangible Assets Current
Technology rights
Finite Lived Intangible Assets Gross
Accumulated amortization
Finite Lived Intangible Assets Accumulated Amortization
Intangible asset, net
Raw materials
Inventory Raw Materials
Work in process
Inventory Work In Process
Finished goods
Inventory Finished Goods
Total inventory
Debt disclosure.
Debt disclosure.
Debt Disclosure [Table]
Debt Disclosure [Table]
Vascepa.
Vascepa
Vascepa [Member]
Related Party
Related Party Transactions By Related Party [Axis]
Related Party
Related Party [Domain]
CPPIB.
CPPIB
C P P I B [Member]
Scenario
Statement Scenario [Axis]
Scenario
Scenario Unspecified [Domain]
Scenario Forecast
Scenario Forecast [Member]
Royalty-bearing debt.
Royalty-Bearing Debt
Royalty Bearing Debt [Member]
Charges cash.
Cash
Charges Cash [Member]
Non-cash.
Non Cash
Non Cash [Member]
Debt Disclosure [Line Items]
Debt Disclosure [Line Items]
Amount received at the closing of the agreement
Proceeds From Issuance Of Long Term Debt
Guarantee payments.
Debt and future repayments net revenues percentage.
Repayment under agreement
Guarantee Payments
Debt and future repayments percentage of net revenues
Debt And Future Repayments Net Revenues Percentage
Long-term debt from royalty-bearing instrument, carrying amount net of unamortized discount
Interest expense, contractual coupon interest
Interest Expense Debt Excluding Amortization
Interest expense, non-cash
Commitments and contingencies disclosure.
Commitments and contingencies disclosure.
Commitments And Contingencies Disclosure [Table]
Commitments And Contingencies Disclosure [Table]
Further indication for AMR101.
Further Indication for AMR101
Further Indication For A M R One Zero One [Member]
Business Developments [Axis]
Business Developments
Business Developments [Axis]
Business Development [Domain]
Business Development
Business Development [Domain]
Marketing approval in Europe.
Marketing Approval In Europe
Marketing Approval In Europe [Member]
Potential marketing approval 1.
Potential Marketing Approval 1
Potential Marketing Approval One [Member]
Potential marketing approval 2.
Potential Marketing Approval 2
Potential Marketing Approval Two [Member]
Commitments And Contingencies Disclosure [Line Items]
Commitments And Contingencies Disclosure [Line Items]
Potential payable amount over the agreement terms based on minimum purchase obligation
Purchase Obligation
Potential aggregate stock or cash payment
Royalty Guarantees Commitments Amount
Private Placement Closing Date
Stockholders Equity Note [Line Items]
Stockholders Equity Note [Table]
Stockholders Equity Note [Table]
Stockholders Equity Note [Table]
Series A Preferred Stock
Series A Preferred Stock [Member]
Preferred shares basis.
Preferred Shares Basis
Preferred Shares Basis [Member]
Ordinary shares basis.
Ordinary Shares Basis
Ordinary Shares Basis [Member]
Subsequent Event Type
Subsequent Event Type [Axis]
Subsequent Event Type
Subsequent Event Type [Domain]
Subsequent Event
Subsequent Event [Member]
Stockholders Equity Note [Line Items]
Stockholders Equity Note [Line Items]
Issuance of stock (shares)
Stock Issued During Period Shares New Issues
American depositary shares conversion rate to preference shares
Preferred Stock Conversion Basis
Private placement, closing date
Private Placement Closing Date
Stock issued under private placement, value
Stock Issued During Period Value New Issues
Equity offering costs.
Conversion price per share.
Share conversion price
Conversion Price Per Share
Aggregate gross proceeds
Proceeds From Issuance Of Private Placement
Estimated offering expense
Equity Offering Costs
Beneficial ownership limitation percentage.
Beneficial ownership limitation
Beneficial Ownership Limitation Percentage
Number of shares issued for each preference shares
Convertible Preferred Stock Shares Issued Upon Conversion
Convertible senior notes, total ADS into which the debt is exchangeable
Stock Issued During Period Shares Conversion Of Convertible Securities
Conversion of stock, shares converted
Conversion Of Stock Shares Converted1
Percentage of outstanding common shares and preferred shares on fully diluted basis.
Award Type
Award Type [Axis]
Award Type
Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]
Performance-based restricted stock units.
Performance-Based RSUs
Performance Based Restricted Stock Units [Member]
Employees member.
Employees
Employees [Member]
Plan Name
Plan Name [Axis]
Plan Name
Plan Name [Domain]
Stock Incentive Plan 2011.
Stock Incentive Plan 2011
Stock Incentive Plan Twenty Eleven [Member]
Stock options, outstanding
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
Restricted stock units, outstanding
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
Percentage of outstanding shares on a fully diluted basis
Percentage Of Outstanding Common Shares And Preferred Shares On Fully Diluted Basis
Shares issued, exercise of stock options
Shares issued, related to the vesting of RSUs
Stock Issued During Period Shares Share Based Compensation
Treasury shares for settlement of employee tax obligations
Shares Paid For Tax Withholding For Share Based Compensation
Stock units, Granted
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
Stock options, Granted
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
Stock units, Vesting Period
Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
Agreement amended date.
Related Party Transactions [Abstract]
Co-promotion agreement.
Co-promotion agreement.
Co Promotion Agreement [Table]
Co Promotion Agreement [Table]
Collaborative Arrangement and Arrangement Other than Collaborative
Type Of Arrangement [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative
Arrangements And Nonarrangement Transactions [Member]
Co promotion agreement.
Co-Promotion Agreement
Co Promotion Agreement [Member]
Counterparty Name
Counterparty Name [Axis]
Counterparty Name
Repurchase Agreement Counterparty Name [Domain]
Kowa Pharmaceuticals America Incorporation.
Kowa Pharmaceuticals America, Inc.
Kowa Pharmaceuticals America Incorporation [Member]
Co Promotion Agreement [Line Items]
Co Promotion Agreement [Line Items]
Agreement amended date
Agreement Amended Date
Percentage of gross margin, payable for promotion agreement.
Co-Promotion tail payments receivable.
Accrued co promotion tail payments.
Maximum co-promotion tail payments receive period.
Promotion fee as a percentage of gross margin
Percentage Of Gross Margin Payable For Promotion Agreement
Maximum co-promotion tail payments receive period
Maximum Co Promotion Tail Payments Receive Period
Co-promotion tail payments receivable
Co Promotion Tail Payments Receivable
Accrued co- promotion tail payments
Accrued Co Promotion Tail Payments
Accrued expenses and other liabilities
Accrued Liabilities And Other Liabilities
Disaggregation Of Revenue [Table]
Disaggregation Of Revenue [Table]
Vascepa 1-gram.
Vascepa 1-Gram
Vascepa One Gram [Member]
Vascepa 0.5-gram.
Vascepa 0.5-Gram
Vascepa Half Gram [Member]
Disaggregation Of Revenue [Line Items]
Disaggregation Of Revenue [Line Items]
Payment period from distributors received from date of sale
Cash discount percent.
Sales discount percentage
Cash Discount Percent
Product expiration period upon conversion into capsule form.
Product expiration date after being converted into capsule form
Product Expiration Period Upon Conversion Into Capsule Form
Provision related to prior period sales.
Credits/payments made for prior period sales.
Valuation allowances provisions and reserves balance net.
Valuation And Qualifying Accounts Disclosure [Table]
Valuation And Qualifying Accounts Disclosure [Table]
Rebates chargebacks and discounts.
Rebates, Chargebacks and Discounts
Rebates Chargebacks And Discounts [Member]
Product returns.
Product Returns
Product Returns [Member]
Other incentive programs.
Other Incentives
Other Incentive Programs [Member]
Valuation And Qualifying Accounts Disclosure [Line Items]
Valuation And Qualifying Accounts Disclosure [Line Items]
Beginning balance
Valuation Allowances Provisions And Reserves Balance Net
Provision related to current period sales
Valuation Allowances And Reserves Charged To Cost And Expense
Provision related to prior period sales
Provision Related To Prior Period Sales
Credits/payments made for current period sales
Valuation Allowances And Reserves Deductions
Credits/payments made for prior period sales
Credits Payments Made For Prior Period Sales
Ending balance
Effect of significant financing component when transfer and customer payment of good or service occurs within one year or less
Revenue Practical Expedient Financing Component
Non-refundable and non-creditable upfront payment.
Payment of milestone.
License And Collaboration Agreements [Line Items]
License And Collaboration Agreements [Table]
License And Collaboration Agreements [Table]
License And Collaboration Agreements [Table]
Mochida Pharmaceutical Co., Ltd.
Mochida
Mochida Pharmaceutical Co Ltd [Member]
In-licenses agreement.
In-licenses
In Licenses Agreement [Member]
Income Statement Location
Income Statement Location [Axis]
Income Statement Location
Income Statement Location [Domain]
Research and Development Expense
Research And Development Expense [Member]
Eddingpharm [Member]
Eddingpharm
Eddingpharm [Member]
Out-licenses agreement.
Out-licenses
Out Licenses Agreement [Member]
Deferred Revenue Arrangement Type
Deferred Revenue Arrangement Type [Axis]
Deferred Revenue
Deferred Revenue Arrangement Type [Domain]
Clinical trial application.
Clinical Trial Application
Clinical Trial Application [Member]
Licensing Revenue
License [Member]
Biologix [Member]
Biologix FZCo
Biologix [Member]
HLS Therapeutics Incorporation.
HLS
H L S Therapeutics Incorporation [Member]
Health, Canada.
Health Canada
Health Canada [Member]
License And Collaboration Agreements [Line Items]
License And Collaboration Agreements [Line Items]
Upfront payment
Non Refundable And Non Creditable Upfront Payment
Milestones payment
Payment Of Milestones
Non refundable upfront payments received.
Nonrefundable milestone payment.
Non-refundable up-front received
Non Refundable Upfront Payments Received
Non-refundable milestone payment
Nonrefundable Milestone Payment
Eligible milestone payment.
Number of regulatory milestone events indications.
Eligible regulatory milestone event payment.
Eligible sales based milestone event payment.
Additional upfront payment eligible to receive based on development, regulatory and sales Milestone
Eligible Milestone Payment
Number of indications of the regulatory milestone events relating to the submission and approval
Number Of Regulatory Milestone Events Indications
Amounts to be received upon achievement of the regulatory milestone events
Eligible Regulatory Milestone Event Payment
Sales-based milestone event payment
Eligible Sales Based Milestone Event Payment
Revenue recognized related to upfront and milestone payments
Contract With Customer Liability Revenue Recognized
Licenses revenue
Deferred revenue
Contract With Customer Liability
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Start Date [Axis]
Revenue recognized over remaining period
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
Estimated number of days following the end of the quarter before related revenue is recognized.
Revenue recognition period of non-refundable up-front payment
Deferred Revenue Recognition Period
Non refundable upfront payments received period.
Non-refundable up-front received period
Non Refundable Upfront Payments Received Period
Nonrefundable milestone payment received.
Non-refundable milestone payment received
Nonrefundable Milestone Payment Received
Contract with customer liability additions.
Contract With Customer Asset And Liability [Abstract]
Contract liabilities:
Contract With Customer Liability [Abstract]
Deferred revenue, Balance at Beginning of Period
Deferred revenue, Additions
Contract With Customer Liability Additions
Deferred revenue, Deductions
Deferred revenue, Balance at End of Period
Contract with customer assets additions.
Contract with Customer asset deductions.
Contract assets, Balance at Beginning of Period
Contract With Customer Asset Net
Contract assets, Additions
Contract With Customer Assets Additions
Contract assets, Deductions
Contract With Customer Asset Deductions
Contract assets, Balance at End of Period
Contract with customer liability revenue recognized excluding performance obligation satisfied in previous period.
Change In Contract With Customer Asset And Liability [Abstract]
Revenue recognized in the period from:
Change In Contract With Customer Liability [Abstract]
Amounts included in contract liability at the beginning of the period
Contract With Customer Liability Revenue Recognized Excluding Performance Obligation Satisfied In Previous Period
Performance obligations satisfied in previous periods
Contract With Customer Performance Obligation Satisfied In Previous Period
Short term lease period.
Lessee Lease Description [Table]
Lessee Lease Description [Table]
Location [Axis]
Location
Location [Axis]
Locations [Domain]
Locations
Locations [Domain]
Dublin [Member]
Dublin
Dublin [Member]
Office centre sharing agreements.
Office Centre Sharing Agreements
Office Centre Sharing Agreements [Member]
Office centre sharing agreements effective May 1, 2019.
Office Centre Sharing Agreements Effective May 1, 2019
Office Centre Sharing Agreements Effective May One Two Thousand And Nineteen [Member]
Bridgewater.
Bridgewater
Bridgewater [Member]
Lessee Lease Description [Line Items]
Lessee Lease Description [Line Items]
Short term lease period
Short Term Lease Period
Operating lease change in weighted average discount rate percent.
Incremental borrowing rate for purposes of calculation of lease liabilities
Operating Lease Weighted Average Discount Rate Percent
Change in incremental borrowing rate
Operating Lease Change In Weighted Average Discount Rate Percent
Lessee operating lease option to additional extend.
Short-term lease payments
Lessee Operating Lease Liability Payments Due Next Twelve Months
Description of lease agreement
Lessee Operating Lease Description
Operating lease, expiration date
Lease Expiration Date1
Lease renewal term
Lessee Operating Lease Renewal Term
Operating lease, option to additional extend
Lessee Operating Lease Option To Additional Extend
Lease termination existence of option to extend
Lessee Operating Lease Existence Of Option To Terminate
Operating lease, existence of option to extend [true false]
Lessee Operating Lease Existence Of Option To Extend
Operating lease, option to extend
Lessee Operating Lease Option To Extend
Number of renewal options.
Operating lease commencement date.
Lease commencement date
Operating Lease Commencement Date
Lease agreement term
Lessee Operating Lease Term Of Contract
Number of renewal options
Number Of Renewal Options
Lease termination description
Lessee Operating Lease Option To Terminate
Monthly rent payment
Lessee Operating Lease Liability Payments Due
Operating lease liability
Operating Lease Liability
Operating lease expense
Operating Lease Expense
Undiscounted lease payments
Operating Lease Liabilities Payments Due [Abstract]
Remainder of 2020
Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
2021
Lessee Operating Lease Liability Payments Due Year Two
2022
Lessee Operating Lease Liability Payments Due Year Three
2023
Lessee Operating Lease Liability Payments Due Year Four
2024
Lessee Operating Lease Liability Payments Due Year Five
2025 and thereafter
Lessee Operating Lease Liability Payments Due After Year Five
Total undiscounted payments
Discount Adjustments
Lessee Operating Lease Liability Undiscounted Excess Amount
Current operating lease liability
Operating Lease Liability Current